These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 33867301)

  • 1. New paradigms for the treatment of pediatric monogenic epilepsies: Progressing toward precision medicine.
    Specchio N; Pietrafusa N; Perucca E; Cross JH
    Epilepsy Behav; 2022 Jun; 131(Pt B):107961. PubMed ID: 33867301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying mutations in epilepsy genes: Impact on treatment selection.
    Perucca P; Perucca E
    Epilepsy Res; 2019 May; 152():18-30. PubMed ID: 30870728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monogenic Epilepsies: Disease Mechanisms, Clinical Phenotypes, and Targeted Therapies.
    Guerrini R; Balestrini S; Wirrell EC; Walker MC
    Neurology; 2021 Oct; 97(17):817-831. PubMed ID: 34493617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developmental and epileptic encephalopathy 82 (DEE82) with novel compound heterozygous mutations of GOT2 gene.
    Çapan ÖY; Türkdoğan D; Atalay S; Çağlayan HS
    Seizure; 2024 Mar; 116():126-132. PubMed ID: 37977948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel treatments in epilepsy guided by genetic diagnosis.
    Marini C; Giardino M
    Br J Clin Pharmacol; 2022 Jun; 88(6):2539-2551. PubMed ID: 34778987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Landscape of Common Epilepsies: Advancing towards Precision in Treatment.
    Thakran S; Guin D; Singh P; Singh P; Kukal S; Rawat C; Yadav S; Kushwaha SS; Srivastava AK; Hasija Y; Saso L; Ramachandran S; Kukreti R
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33096746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early-Life Epilepsies.
    Akiyama LF; Saneto RP
    Pediatr Ann; 2023 Oct; 52(10):e381-e387. PubMed ID: 37820708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precision Medicine Approaches for Infantile-Onset Developmental and Epileptic Encephalopathies.
    Myers KA; Scheffer IE
    Annu Rev Pharmacol Toxicol; 2022 Jan; 62():641-662. PubMed ID: 34579535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What are the considerations when initiating treatment for epilepsy in children?
    Pisani F; Spagnoli C
    Expert Rev Neurother; 2023; 23(12):1081-1096. PubMed ID: 38032395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Channelopathies in epilepsy: an overview of clinical presentations, pathogenic mechanisms, and therapeutic insights.
    Ng AC; Chahine M; Scantlebury MH; Appendino JP
    J Neurol; 2024 Jun; 271(6):3063-3094. PubMed ID: 38607431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seizure-suppressor genes: can they help spearhead the discovery of novel therapeutic targets for epilepsy?
    Silva-Cardoso GK; N'Gouemo P
    Expert Opin Ther Targets; 2023; 27(8):657-664. PubMed ID: 37589085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developmental and epileptic encephalopathies: Is prognosis related to different epileptic network dysfunctions?
    Lin JJ; Meletti S; Vaudano AE; Lin KL
    Epilepsy Behav; 2022 Jun; 131(Pt B):107654. PubMed ID: 33349540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Epileptic Encephalopathies.
    Balestrini S; Sisodiya SM
    Curr Pharm Des; 2017; 23(37):5667-5690. PubMed ID: 28799511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics and treatment experience of individuals with SCN8A developmental and epileptic encephalopathy (SCN8A-DEE): Findings from an online caregiver survey.
    Cutts A; Savoie H; Hammer MF; Schreiber J; Grayson C; Luzon C; Butterfield N; Pimstone SN; Aycardi E; Harden C; Yonan C; Jen E; Nguyen T; Carmack T; Haubenberger D
    Seizure; 2022 Apr; 97():50-57. PubMed ID: 35325842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monogenic idiopathic epilepsies.
    Gourfinkel-An I; Baulac S; Nabbout R; Ruberg M; Baulac M; Brice A; LeGuern E
    Lancet Neurol; 2004 Apr; 3(4):209-18. PubMed ID: 15039033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From Genetic Testing to Precision Medicine in Epilepsy.
    Striano P; Minassian BA
    Neurotherapeutics; 2020 Apr; 17(2):609-615. PubMed ID: 31981099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene Therapy: Novel Approaches to Targeting Monogenic Epilepsies.
    Goodspeed K; Bailey RM; Prasad S; Sadhu C; Cardenas JA; Holmay M; Bilder DA; Minassian BA
    Front Neurol; 2022; 13():805007. PubMed ID: 35847198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Pharmacoresistant Epilepsy: An Overview on Existent and New Emerging Therapies.
    Fattorusso A; Matricardi S; Mencaroni E; Dell'Isola GB; Di Cara G; Striano P; Verrotti A
    Front Neurol; 2021; 12():674483. PubMed ID: 34239494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exome sequencing reveals new causal mutations in children with epileptic encephalopathies.
    Veeramah KR; Johnstone L; Karafet TM; Wolf D; Sprissler R; Salogiannis J; Barth-Maron A; Greenberg ME; Stuhlmann T; Weinert S; Jentsch TJ; Pazzi M; Restifo LL; Talwar D; Erickson RP; Hammer MF
    Epilepsia; 2013 Jul; 54(7):1270-81. PubMed ID: 23647072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA therapeutics for epilepsy: An emerging modality for drug discovery.
    Hansen SN; Holm A; Kauppinen S; Klitgaard H
    Epilepsia; 2023 Dec; 64(12):3113-3129. PubMed ID: 37703096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.